Sales Concentration Among Major Wholesalers
First written in FY2024. . Latest entry: FY2026.
The whole theme swung hardest in 2024: 2 of 12 companies on the "Worse" side.
10 other companies' latest entry also says "Other".
- FY2026Concentration of sales among major wholesalers updatedAnnual report
「Sales to major customers and their percentage of total sales Customer Previous fiscal year Current fiscal year Sales (¥ million) Percentage (%) Sales (¥ million) Percentage (%) ㈱スズケン 8,357 13.8 11,667 18.7 アルフレッサ㈱ 9,325 15.4 11,189 18.0 ㈱メディセオ 9,036 14.9 9,697 15.6 東邦薬品㈱ 5,260 8.7 7,312 11.7」
Sales to the 4 major wholesalers accounted for a combined 64.0%, up from 52.8% in the previous fiscal year. - FY2025Concentration of sales among major wholesalers updatedAnnual report
「Sales to major customers and their percentage of total sales アルフレッサ㈱ 9,325 15.4 ㈱メディセオ 9,036 14.9 ㈱スズケン 8,357 13.8 東邦薬品㈱ 5,260 8.7」
Sales to the 4 major wholesalers totaled ¥3,197.8 million, accounting for 52.8% of total sales. Concentration decreased from the 63.4% combined share of the 4 companies in the previous fiscal year. - FY2024First statedAnnual report
「Sales to major customers and their percentage of total sales: ㈱スズケン ¥10,889 million 19.7%; アルフレッサ㈱ ¥9,719 million 17.5%; ㈱メディセオ ¥7,816 million 14.1%; 東邦薬品㈱ ¥6,678 million 12.1%」
The company disclosed that sales to 4 companies accounted for a combined 63.4% of total sales for the year, indicating concentration among multiple major pharmaceutical wholesalers.